Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Infiltrating Lymphocytes”

252 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 252 results

Early research (Phase 1)Ended earlyNCT05573035
What this trial is testing

Investigate LYL845 in Adults With Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerColorectal Cancer
Lyell Immunopharma, Inc. 39
Early research (Phase 1)Active Not RecruitingNCT05176470
What this trial is testing

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

Who this might be right for
Locally Advanced MelanomaPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more
Richard Wu 2
Early research (Phase 1)Ended earlyNCT05576077
What this trial is testing

TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerUveal Melanoma+3 more
Turnstone Biologics, Corp. 31
Very early researchNot Yet RecruitingNCT07498595
What this trial is testing

TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC

Who this might be right for
EGFR-TKI-resistant Non-Small Cell Lung Cancer
Tianjin Medical University General Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Not applicableStudy completedNCT03539965
What this trial is testing

Triple-negative Breast Cancer: a New Perspective on Biomarkers

Who this might be right for
Triple Negative Breast NeoplasmsTriple Negative Breast Cancer
Instituto Nacional de Cancer, Brazil 239
Testing effectiveness (Phase 2)Looking for participantsNCT06598371
What this trial is testing

KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

Who this might be right for
Select Advanced Solid Tumors
M.D. Anderson Cancer Center 141
Testing effectiveness (Phase 2)Study completedNCT01319565
What this trial is testing

Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 102
Testing effectiveness (Phase 2)Study completedNCT02818920
What this trial is testing

Neoadjuvant Pembrolizumab

Who this might be right for
Non-small Cell Lung Carcinoma
Neal Ready MD PhD 35
Not applicableEnrolling By InvitationNCT06763640
What this trial is testing

Prognostic Value of TIL in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Jiangxi Provincial Cancer Hospital 216
Testing effectiveness (Phase 2)Study completedNCT02383498
What this trial is testing

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

Who this might be right for
Chordoma
NantCell, Inc. 24
Early research (Phase 1)Looking for participantsNCT06084299
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
Zhiyong Huang 16
Large-scale testing (Phase 3)Looking for participantsNCT05727904
What this trial is testing

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Who this might be right for
Metastatic MelanomaUnresectable MelanomaMelanoma
Iovance Biotherapeutics, Inc. 670
Testing effectiveness (Phase 2)Looking for participantsNCT06640582
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Who this might be right for
Brain TumorBrain MetastasesBrain Cancer+4 more
Essen Biotech 85
Testing effectiveness (Phase 2)Looking for participantsNCT06060613
What this trial is testing

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Who this might be right for
Tumor SkinMetastatic MelanomaMelanoma+4 more
Obsidian Therapeutics, Inc. 208
Testing effectiveness (Phase 2)Ended earlyNCT03108495
What this trial is testing

Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

Who this might be right for
Cervical Carcinoma
Iovance Biotherapeutics, Inc. 210
Early research (Phase 1)Ended earlyNCT05107739
What this trial is testing

DeTIL-0255 in Adults With Advanced Malignancies

Who this might be right for
Platinum-resistant Ovarian CancerEndometrial CancerCervical Cancer
Nurix Therapeutics, Inc. 5
Not applicableEnded earlyNCT02464904
What this trial is testing

Intrapleural Cryotherapy for Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Mayo Clinic 17
Very early researchLooking for participantsNCT04943913
What this trial is testing

Study of GC101 TIL in Brain Glioma (Soochow2)

Who this might be right for
Glioma
Shanghai Juncell Therapeutics 50
Testing effectiveness (Phase 2)Study completedNCT02269943
What this trial is testing

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Celgene 36
Next Page